Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
The Long Run with Luke Timmerman
00:00
Fundraising, biomarkers, and regulatory pathway
Emily discusses successful fundraising, kidney biomarkers like total kidney volume, and FDA accelerated approval prospects.
Play episode from 55:11
Transcript
